Hendrikx, B.; Brys, E.-A.; Dili, A.; Apers, T.; Hartman, V.; Brichard, M.; Gryspeerdt, F.; Bertrand, C.; Roeyen, G.; Berrevoet, F.
Use of Irreversible Electroporation in Pancreatic Cancer Patients: A Multi-Center Experience. Curr. Oncol. 2025, 32, 574.
https://doi.org/10.3390/curroncol32100574
AMA Style
Hendrikx B, Brys E-A, Dili A, Apers T, Hartman V, Brichard M, Gryspeerdt F, Bertrand C, Roeyen G, Berrevoet F.
Use of Irreversible Electroporation in Pancreatic Cancer Patients: A Multi-Center Experience. Current Oncology. 2025; 32(10):574.
https://doi.org/10.3390/curroncol32100574
Chicago/Turabian Style
Hendrikx, Bart, Eline-Alice Brys, Alexandra Dili, Thomas Apers, Vera Hartman, Martin Brichard, Filip Gryspeerdt, Claude Bertrand, Geert Roeyen, and Frederik Berrevoet.
2025. "Use of Irreversible Electroporation in Pancreatic Cancer Patients: A Multi-Center Experience" Current Oncology 32, no. 10: 574.
https://doi.org/10.3390/curroncol32100574
APA Style
Hendrikx, B., Brys, E.-A., Dili, A., Apers, T., Hartman, V., Brichard, M., Gryspeerdt, F., Bertrand, C., Roeyen, G., & Berrevoet, F.
(2025). Use of Irreversible Electroporation in Pancreatic Cancer Patients: A Multi-Center Experience. Current Oncology, 32(10), 574.
https://doi.org/10.3390/curroncol32100574
